ジェダイトメディスン

Jadeite Medicines Inc. was established for Japanese patients with its mission of developing and commercializing novel innovative medicines developed globally.

Jadeite Medicines Inc. aims to become the best partner for innovative companies around the world and to meet the unmet medical needs in Japan.

5th April 2024 Jadeite Medicines to initiate Phase 3 Trial of Odevixibat in Alagille Syndrome in Japan >>>Press Release
(Details here)